Items which should not routinely be prescribed in primary care

In November 2017 NHS England issued guidance to CCGs to stop or reduce prescribing of 18 treatments considered ineffective, unsafe or of low clinical value.

The guidance included products such as homeopathy, herbal remedies and co-proxamol (a pain killer which has had its marketing authorisation withdrawn due to safety concerns). 

The guidance can be found at:

In response to the national guidance the CCG has been working with local GPs, hospital specialists and patient groups to implement the guidance.  The CCG has developed policy statements and patient information leaflets for each of the 18 products which can be found here:

Building on the national guidance NHS England has launched a consultation in November 2018 on a further eight products:

•    Aliskiren
•    Amiodarone
•    Bath and shower preparations for dry and pruritic skin conditions
•    Blood glucose testing strips for type 2 diabetes
•    Dronedarone
•    Minocycline for acne
•    Needles for Pre-Filled and Reusable Insulin Pens
•    Silk Garments

Full details of the proposed guidance (including an easy read version) and how to respond to the consultation is available at:
latest consultation on items which should not routinely be prescribed in primary care

The consultation closes on 28 February 2018

NHS image of consultation